Evolution of the ovarian stimulation in IVF;Evolution de la stimulation ovarienne en fecondation in vitro

Revue Medicale de Bruxelles

Volumn 20, Issue 5, 1999, Pages

  Delbaere, A ^a   Devreker, F ^a   Hannes, M ^a   Koenig, I ^a   Holoye, A ^a   Englert, Y ^a  

^a ERASME HOSPITAL   (Belgium)

Author keywords

GnRH analogous; GnRH antagonists; Gonadotrophins; IVF; Ovarian stimulation

Indexed keywords

FOLLITROPIN; FOLLITROPIN DERIVATIVE; GONADOTROPIN; GONADOTROPIN ANTAGONIST; HUMAN MENOPAUSAL GONADOTROPIN; LUTEINIZING HORMONE; RECOMBINANT FOLLITROPIN; UNCLASSIFIED DRUG; UROFOLLITROPIN;

DRUG FORMULATION; EMBRYO TRANSFER; FERTILIZATION IN VITRO; HUMAN; IMMUNOGENICITY; OOCYTE; OVARY FOLLICLE DEVELOPMENT; OVARY HYPERSTIMULATION; REVIEW; TREATMENT PLANNING;

CLOMIPHENE; FEMALE; FERTILITY AGENTS, FEMALE; FERTILIZATION IN VITRO; GONADOTROPIN-RELEASING HORMONE; GONADOTROPINS; HUMANS; MENOTROPINS; OVULATION INDUCTION; PREGNANCY; PREGNANCY OUTCOME;

EID: 0032716187     PISSN: 00353639     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (34)

1. Steptoe PC, Edwards RG : Birth after re-implantation of a human embryo. Lancet 1978 ; ii : 366
2. Trounson AO, Leeton JF, Wood C, Webb J, Wood J : Pregnancies in human by fertilization in vitro and embryo transfer in the controlled ovulatory cycle. Science 1981 ; 212 : 681-2
3. Laufer N, Tarlatzis BC, Naftolin F : In vitro fertilization : state of the art. Semin Reprod Endocinol 1984; 2: 197-219
4. Smitz J, Ron-El R, Tarlatzis BC : The use of gonadotrophin releasing hormone agonists for in vitro fertilization and other assisted procreation techniques : Experience from three centres. Human Reprod 1992 ; 7 : 49-66
5. Filicori M, Cognigni GE, Arnone R, Carbone F, Falbo A, Tabarelli C et al : Role of different GnRH agonist regimens in pituitary suppression and the outcome of controlled ovarian hyperstimulation. Human Reprod 1996; 11 : 123-32
6. Insler V, Lunenfeld B : Application of GnRH analogues in the management of female infertility. In : Lunenfeld B, Insler V, eds. GnRH analogues. The State of the Art. Carnforth, Parthenon Publishing 1996: 55-69
7. Hughes J-N, Cédrin Durnerin I : Revisiting gonadotrophin-releasing hormone agonist protocols and management of poor ovarian responses to gonadotrophins. Human Reprod Update 1998 ; 4: 83-101
8. Hughes EG, Sagle MA, Fedorkow DM, Van de Koppel P, Daya S, Collins JA : The routine use of gonadotropin-releasing hormone agonists prior to in vitro fertilization and gamete intrafallopian transfer : a meta-analysis of randomized controlled trials. Fertil Steril 1992 ; 58 : 888-96
9. Devreker F, Govaerts I, Bertrand E, Van den Bergh M, Gervy C, Englert Y : The long-acting gonadotropin-releasing hormone analogues impaired the implantation rate. Fertil Steril 1996 ; 65: 122-6
10. Gemzell CA, Diczfaluzy E, Tillinger KG : Human pituitary follicle-stimulating hormone I : clinical effect of a partly purified preparation. Ciba Found Colloq Endocrinol 1960; 13: 191
11. Lunenfeld B, Sulimovici S, Rabau E, Eshkol A: L'induction de l'ovulation dans les aménorrhées hypophysaires par un traitement combiné de gonadotrophines urinaires ménopausiques et de gonadotrophines chorioniques. C R Soc Fr Gynécol 1962 ; 5 : 30
12. Loumaye E, Campbell R, Salat-Baroux J : Human follicle-stimulating hormone produced by recombinant DNA technology : a review for clinicians. Human Reprod Update 1995 ; 1 : 188-99
13. Shaw RW, Ndukwe G, Imoedemhe DAG, Bernard AG, Burford G :Twin pregnancy after pituitary desensitization with LHRH agonist and pure FSH. Lancet 1985 ; ii : 506
14. Daya S, Gunby J, Hughes EG, Collins JA, Sagle MA : Follicle-stimulating hormone versus human menopausal gonadotropin for in vitro fertilization cycles : a meta-analysis. Fertil Steril 1995; 64: 347-54
15. Howles CM, Loumaye E, Giroud D, Luyet G : Multiple follicular development and ovarian steroidogenesis following subcutaneous administration of a highly purified urinary FSH preparation (Metrodin HP) in pituitary desensitized women undergoing IVF/ET : a multicenter European phase III study. Human Reprod 1994 ; 9 : 424-30
16. Devroey P, Mannaerts B, Smitz J, Coelingh Bennink H, Van Steirteghem A : Clinical outcome of a pilot efficacy study on recombinant human follicle-stimulating hormone (Org 32489) combined with various gonadotrophin-releasing hormone agonist regimens. Human Reprod 1994 ; 9 : 1064-9
17. Recombinant human FSH Study Group : Clinical assessment of recombinant human follicle-stimulating hormone in stimulating ovarian follicular development before in vitro fertilization. Fertil Steril 1995 ; 63 : 77-86
18. Out HJ, Mannaerts BMJL, Driessen SGAJ, Coelingh Bennink HJT : A prospective, randomized, assessor-blind, multicentre study comparing recombinant and urinary follicle stimulating hormone (Puregon versus Metrodin) in in vitro fertilization. Human Reprod 1995; 10: 2534-40
19. Hedon B, Out HJ, Camier B, Cohen J, Lopes P, Zorn JR et al : Efficacy and safety of recombinant follicle stimulating hormone (Puregon®) in infertile women pituitary-suppressed with triptorelin undergoing in-vitro fertilization : a prospective, randomized, assessor-blind, multicentre trial. Human Reprod 1995 ; 10: 3102-6
20. Bergh C, Howles CM, Borg K, Hamberger L, Josefsson B, Nilsson L, Wikland M : Recombinant human follicle stimulating hormone (r-hFSH ; Gonal-F®) versus highly purified urinary FSH (Metrodin HP®) : results of a randomized comparative study in women undergoing assisted reproductive techniques. Human Reprod 1997; 12: 2133-9
21. Jansen CAM, van Os Heleentje, Out HJ, Coelingh Bennink HJT : A prospective randomized clinical trial comparing recombinant follicle stimulating hormone (Puregon®) and human menopausal gonadotrophins (Humegon®) in non-down-regulated in-vitro fertilization patients. Human Reprod 1998; 13: 2995-9
22. Diedrich K, Diedrich C, Santos E, Zoll C, Al-Hasani S, Reissman T et al : Suppression of the endogenous LH-surge by the GnRH antagonist cetrorelix during ovarian stimulation. Human Reprod 1994 ; 9 : 788-91
23. Olivennes F, Fanchin R, Bouchard P, de Ziegler D, Taieb J, Selva J et al : The single or dual administration of the GnRH antagonist cetrorelix prevents premature LH surges in an IVF-embryo transfer program. Fertil Steril 1994 ; 62 : 468-76
24. Albano C, Smitz J, Camus M, Riethmuiler-Winzen H, Van Steireghem A, Devroey P : Comparison of different doses of gonadotropin-releasing hormone antagonist cetrorelix during controlled ovarian hyperstimulation. Fertil Steril 1997 ; 67: 917-22
25. The ganirelix dose-finding study group : A double-blind, randomized, dose-finding study to assess the efficacy of the gonadotrophin-releasing hormone antagonist ganireiix (Org 37462) to prevent premature luteinizing hormone surges in women undergoing ovarian stimulation with recombinant follicle stimulating hormone (Puregon®). Human Reprod 1998 ; 13: 3023-31
26. Olivennes F, Alvarez S, Bouchard P, Fanchin R, Salat-Baroux J, Frydman R : The use of a GnRH antagonist (cetrorelix) in a single dose protocol in IVF-embryo transfer : a dose finding study of 3 versus 2 mg. Human Reprod 1998 ; 13: 2411-4
27. Englert Y : Les caractéristiques du sperme et la fécondation in vitro humaine. Travail de thèse pour l'obtention du titre d'agrégé de l'enseignement supérieur, Université Libre de Bruxelles, 1992
28. Devreker F, Emiliani S, Revelard P, Van den Bergh M, Govaerts I, Englert Y : Comparison of two elective transfer policies of two embryos to reduce multiple pregnancies without impairing pregnancy rates. Human Reprod 1999 ; 14 : 83-9
29. Govaerts I, Devreker F, Delbaere A, Revelard P, Englert Y : Short-term medical complications of 1500 oocyte retrievals for in vitro fertilization and embryo transfer. Eur J Obstet Gynecol Reprod Biol 1998 ; 77 : 239-43
30. Hollemaert S, Wautrecht J-C, Capel P, Abramowicz MJ, Englert Y, Delbaere A : Thrombosis associated with ovarian hyperstimulation syndrome in a carrier of the factor V Leiden mutation. Thromb Haemost 1996 ; 76 : 275-6
31. Delbaere A, Bergmann PJM, Gervy-Decoster C, Deschodt-Lanckman M, de Maertelaer V, Staroukine M et al : Increased angiotensin II in ascites during severe ovarian hyperstimulation syndrome : role of early pregnancy and ovarian gonadotrophin stimulation. Fertil Steril 1997 ; 67 : 1038-45
32. Tarlatzis BC, Grimbizis G, Bontis J, Mantalenakis S : Ovarian stimulation and ovarian tumours : a critical reappraisal. Human Reprod Update 1995; 1 : 284-301
33. Edwards RG, Lobo R, Bouchard P : Time to revolutionize ovarian stimulation. Human Reprod 1996; 11 : 917-9
34. Devreker F, Pogonici E, de Maertelaer V, Revelard P, Van den Bergh M, Englert Y : Selection of good embryos for transfer depends on embryo cohort size : implication for the "soft ovarian stimulation debate". Human Reprod, soumis.